DE69123880D1 - Verfahren zur Herstellung von Eicosapentaensäure oder von einem Esterderivat davon - Google Patents
Verfahren zur Herstellung von Eicosapentaensäure oder von einem Esterderivat davonInfo
- Publication number
- DE69123880D1 DE69123880D1 DE69123880T DE69123880T DE69123880D1 DE 69123880 D1 DE69123880 D1 DE 69123880D1 DE 69123880 T DE69123880 T DE 69123880T DE 69123880 T DE69123880 T DE 69123880T DE 69123880 D1 DE69123880 D1 DE 69123880D1
- Authority
- DE
- Germany
- Prior art keywords
- ester derivative
- eicosapentaenoic acid
- preparation
- present
- continuous distillation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title abstract 5
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical class CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 title abstract 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 title abstract 2
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 title abstract 2
- 235000020673 eicosapentaenoic acid Nutrition 0.000 title abstract 2
- 150000002148 esters Chemical class 0.000 title abstract 2
- 238000001944 continuous distillation Methods 0.000 abstract 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 abstract 1
- 239000004202 carbamide Substances 0.000 abstract 1
- 238000010276 construction Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/42—Separation; Purification; Stabilisation; Use of additives
- C07C51/43—Separation; Purification; Stabilisation; Use of additives by change of the physical state, e.g. crystallisation
- C07C51/44—Separation; Purification; Stabilisation; Use of additives by change of the physical state, e.g. crystallisation by distillation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/42—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/48—Separation; Purification; Stabilisation; Use of additives
- C07C67/52—Separation; Purification; Stabilisation; Use of additives by change in the physical state, e.g. crystallisation
- C07C67/54—Separation; Purification; Stabilisation; Use of additives by change in the physical state, e.g. crystallisation by distillation
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2145617A JP3040136B2 (ja) | 1990-06-04 | 1990-06-04 | エイコサペンタエン酸またはそのエステルの製造方法 |
JP2145618A JP3005638B2 (ja) | 1990-06-04 | 1990-06-04 | 高濃度エイコサペンタエン酸またはそのエステルの製造方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69123880D1 true DE69123880D1 (de) | 1997-02-13 |
DE69123880T2 DE69123880T2 (de) | 1997-07-03 |
Family
ID=26476703
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69123880T Expired - Fee Related DE69123880T2 (de) | 1990-06-04 | 1991-06-04 | Verfahren zur Herstellung von Eicosapentaensäure oder von einem Esterderivat davon |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0460917B1 (de) |
JP (1) | JPH11236591A (de) |
KR (1) | KR100208701B1 (de) |
AT (1) | ATE147062T1 (de) |
AU (1) | AU641016B2 (de) |
CA (1) | CA2043615C (de) |
DE (1) | DE69123880T2 (de) |
DK (1) | DK0460917T3 (de) |
ES (1) | ES2095909T3 (de) |
GR (1) | GR3022660T3 (de) |
NO (1) | NO177699C (de) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3400466B2 (ja) * | 1991-10-28 | 2003-04-28 | 日本水産株式会社 | 高純度エイコサペンタエン酸またはそのエステルの製造方法 |
NO322213B1 (no) * | 1998-01-30 | 2006-08-28 | Ube Industries | Fremgangsmåte for rensing av varmenedbrytbare aromatiske hydroksylforbindelser ved destillasjon hvor de varmenedbrytbare aromatiske hydroksylforbindelsene befinner seg i en flerkomponentholdig væskeblanding. |
NZ332331A (en) * | 1998-10-15 | 2000-03-27 | Craig Nazzer | Continuous process for removing solids from miscible liquid mixture; lower boiling point liquid(s) removed by flashing or boiling |
GB9901809D0 (en) | 1999-01-27 | 1999-03-17 | Scarista Limited | Highly purified ethgyl epa and other epa derivatives for psychiatric and neurological disorderes |
JP4558870B2 (ja) | 1999-11-08 | 2010-10-06 | 株式会社日本触媒 | 塔式処理方法および装置 |
FR2833006A1 (fr) * | 2001-11-30 | 2003-06-06 | Cognis France Sa | Procede de preparation d'ester methylique d'acide oleique industriel |
US20110236476A1 (en) | 2008-09-02 | 2011-09-29 | Amarin Corporation Plc. | Pharmaceutical composition comprising eicosapentaenoic acid and nicotinic acid and methods of using same |
KR20140007973A (ko) | 2009-02-10 | 2014-01-20 | 아마린 파마, 인크. | 고중성지방혈증 치료 방법 |
NZ624963A (en) | 2009-04-29 | 2016-07-29 | Amarin Pharmaceuticals Ie Ltd | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same |
NZ627238A (en) | 2009-04-29 | 2016-02-26 | Amarin Pharmaceuticals Ie Ltd | Stable pharmaceutical composition comprising ethyl eicosapentaenoate |
MY172372A (en) | 2009-06-15 | 2019-11-21 | Amarin Pharmaceuticals Ie Ltd | Compositions and methods for lowering triglycerides |
WO2011038122A1 (en) | 2009-09-23 | 2011-03-31 | Amarin Corporation Plc | Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same |
US11712429B2 (en) | 2010-11-29 | 2023-08-01 | Amarin Pharmaceuticals Ireland Limited | Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity |
NZ744990A (en) | 2010-11-29 | 2019-10-25 | Amarin Pharmaceuticals Ie Ltd | Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity |
CN102417447B (zh) * | 2011-10-31 | 2014-04-30 | 广西亿康药业股份有限公司 | 十一烯酸的生产方法 |
US20130131170A1 (en) | 2011-11-07 | 2013-05-23 | Amarin Pharmaceuticals Ireland Limited | Methods of treating hypertriglyceridemia |
US11291643B2 (en) | 2011-11-07 | 2022-04-05 | Amarin Pharmaceuticals Ireland Limited | Methods of treating hypertriglyceridemia |
EP2800469B1 (de) | 2012-01-06 | 2021-08-25 | Amarin Pharmaceuticals Ireland Limited | Zusammensetzungen und verfahren zur senkung der konzentration an hochsensitivem c-reaktiven protein (hs-crp) bei einer person |
ES2900618T3 (es) | 2012-05-14 | 2022-03-17 | Nippon Suisan Kaisha Ltd | Acido graso altamente insaturado o etil éster de ácido graso altamente insaturado con contaminantes ambientales reducidos y método para la producción de los mismos |
CN102776067A (zh) * | 2012-05-31 | 2012-11-14 | 源华能源科技(福建)有限公司 | 一种分子蒸馏提纯粗脂肪酸甲酯工艺 |
EP2866801A4 (de) | 2012-06-29 | 2016-02-10 | Amarin Pharmaceuticals Ie Ltd | Verfahren zur verringerung des risikos von herz-kreislauf-ereignissen bei einem patienten in einer statintherapie |
WO2014074552A2 (en) | 2012-11-06 | 2014-05-15 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy |
US9814733B2 (en) | 2012-12-31 | 2017-11-14 | A,arin Pharmaceuticals Ireland Limited | Compositions comprising EPA and obeticholic acid and methods of use thereof |
US20140187633A1 (en) | 2012-12-31 | 2014-07-03 | Amarin Pharmaceuticals Ireland Limited | Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis |
US9452151B2 (en) | 2013-02-06 | 2016-09-27 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing apolipoprotein C-III |
US9624492B2 (en) | 2013-02-13 | 2017-04-18 | Amarin Pharmaceuticals Ireland Limited | Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof |
US9662307B2 (en) | 2013-02-19 | 2017-05-30 | The Regents Of The University Of Colorado | Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof |
US9283201B2 (en) | 2013-03-14 | 2016-03-15 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for treating or preventing obesity in a subject in need thereof |
US20140271841A1 (en) | 2013-03-15 | 2014-09-18 | Amarin Pharmaceuticals Ireland Limited | Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin |
US10966968B2 (en) | 2013-06-06 | 2021-04-06 | Amarin Pharmaceuticals Ireland Limited | Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof |
US20150065572A1 (en) | 2013-09-04 | 2015-03-05 | Amarin Pharmaceuticals Ireland Limited | Methods of treating or preventing prostate cancer |
US9585859B2 (en) | 2013-10-10 | 2017-03-07 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy |
CN103570590B (zh) * | 2013-10-30 | 2016-04-06 | 临沂远博化工有限公司 | 一种生产硫酸二甲酯的设备 |
HUE055277T2 (hu) | 2013-12-04 | 2021-11-29 | Nippon Suisan Kaisha Ltd | Dihomo-gamma-linolénsavat tartalmazó mikrobális olaj és dihomo-gamma-linolénsavat tartalmazó mikrobális biomassza |
US10561631B2 (en) | 2014-06-11 | 2020-02-18 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing RLP-C |
WO2015195662A1 (en) | 2014-06-16 | 2015-12-23 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing or preventing oxidation of small dense ldl or membrane polyunsaturated fatty acids |
EP3196280A4 (de) | 2014-09-17 | 2018-04-11 | Nippon Suisan Kaisha, Ltd. | Zusammensetzung mit eicosapentaensäurealkylester und verfahren zur herstellung davon |
US10406130B2 (en) | 2016-03-15 | 2019-09-10 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids |
WO2018213663A1 (en) | 2017-05-19 | 2018-11-22 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides in a subject having reduced kidney function |
US11058661B2 (en) | 2018-03-02 | 2021-07-13 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L |
KR102296068B1 (ko) | 2018-09-24 | 2021-09-02 | 애머린 파마슈티칼스 아일랜드 리미티드 | 대상체에서 심혈관 사건의 위험도를 감소시키는 방법 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2055892C3 (de) * | 1970-11-13 | 1979-08-16 | Basf Ag, 6700 Ludwigshafen | Verfahren zur Reinigung von Butandiol |
DE2220922C2 (de) * | 1972-04-28 | 1985-06-20 | Feld & Hahn Gmbh, 5413 Bendorf | Verfahren und Vorrichtung zur Abtrennung von Fettsäuren durch Destillation |
JPS57149400A (en) * | 1981-03-12 | 1982-09-14 | Kureha Chemical Ind Co Ltd | Manufacture of high purity long chain highly unsaturated fatty acid ester |
JPS588037A (ja) * | 1981-07-03 | 1983-01-18 | Nippon Suisan Kaisha Ltd | エイコサペンタエン酸またはそのエステルの製法 |
US4377526A (en) * | 1981-05-15 | 1983-03-22 | Nippon Suisan Kaisha, Ltd. | Method of purifying eicosapentaenoic acid and its esters |
DE3226116A1 (de) * | 1981-07-16 | 1983-02-03 | VEB Chemieanlagenbaukombinat Leipzig-Grimma, DDR 7240 Grimma | Verfahren und vorrichtung zur kontinuierlichen rektifikation von mehr- und vielstoffgemischen |
GB2218984B (en) * | 1988-05-27 | 1992-09-23 | Renafield Limited | Process for preparing high-concentration mixtures of polyunsaturated fatty acids & their esters and their prophylactic or therapeutic uses |
JPH02268133A (ja) * | 1989-04-10 | 1990-11-01 | Nippon Suisan Kaisha Ltd | エイコサペンタエン酸またはそのエステルの製造法 |
-
1991
- 1991-06-03 CA CA002043615A patent/CA2043615C/en not_active Expired - Fee Related
- 1991-06-04 KR KR1019910009345A patent/KR100208701B1/ko not_active IP Right Cessation
- 1991-06-04 AT AT91305044T patent/ATE147062T1/de not_active IP Right Cessation
- 1991-06-04 NO NO912144A patent/NO177699C/no unknown
- 1991-06-04 DE DE69123880T patent/DE69123880T2/de not_active Expired - Fee Related
- 1991-06-04 EP EP91305044A patent/EP0460917B1/de not_active Expired - Lifetime
- 1991-06-04 AU AU78186/91A patent/AU641016B2/en not_active Ceased
- 1991-06-04 ES ES91305044T patent/ES2095909T3/es not_active Expired - Lifetime
- 1991-06-04 DK DK91305044.9T patent/DK0460917T3/da active
-
1997
- 1997-02-26 GR GR970400347T patent/GR3022660T3/el unknown
-
1998
- 1998-12-14 JP JP10354409A patent/JPH11236591A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP0460917A2 (de) | 1991-12-11 |
KR100208701B1 (ko) | 1999-07-15 |
DK0460917T3 (da) | 1997-01-20 |
KR920000690A (ko) | 1992-01-29 |
JPH11236591A (ja) | 1999-08-31 |
NO177699B (no) | 1995-07-31 |
DE69123880T2 (de) | 1997-07-03 |
NO177699C (no) | 1995-11-08 |
ATE147062T1 (de) | 1997-01-15 |
CA2043615C (en) | 2001-08-14 |
EP0460917B1 (de) | 1997-01-02 |
AU641016B2 (en) | 1993-09-09 |
NO912144D0 (no) | 1991-06-04 |
ES2095909T3 (es) | 1997-03-01 |
AU7818691A (en) | 1991-12-05 |
EP0460917A3 (en) | 1993-07-07 |
CA2043615A1 (en) | 1991-12-05 |
NO912144L (no) | 1991-12-05 |
GR3022660T3 (en) | 1997-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69123880D1 (de) | Verfahren zur Herstellung von Eicosapentaensäure oder von einem Esterderivat davon | |
DE69201959D1 (de) | Verfahren zur Herstellung von 6,12-Dihydro-6-hydroxy-cannabidiol und dessen Anwendung zur Herstellung von trans-delta-9-Tetrahydrocannabinol. | |
ATE137493T1 (de) | Verfahren zur herstellung von zwischenprodukten zur verwendung in der herstellung von alkoxyiminoacetamide | |
DE69016590D1 (de) | Verfahren zur Herstellung von Acrylsäure. | |
DE68913714T2 (de) | Verfahren zur Herstellung von ungesättigter Carbonsäure oder ihrem Ester. | |
DE69007800D1 (de) | Verfahren zur fermentativen Herstellung von L-Arginin. | |
DE69011880D1 (de) | Verfahren zur Herstellung von L-Aminosäuren durch Fermentation. | |
DE3882453D1 (de) | Verfahren zur herstellung von ibuprofen. | |
ATE204283T1 (de) | Verfahren zur herstellung von 2,2- difluorketensilylacetalen und alpha,alpha-difluor-beta -silyloxy-1,3-dioxolan-4-propansäureestern | |
DE69008070T2 (de) | Verfahren zur Herstellung eines alpha-Ketocarbonsäureester. | |
DE69112716T2 (de) | Verfahren zur biologischen Herstellung einer Hydroxyvitamin-D-Verbindung. | |
ATE125731T1 (de) | Verfahren zur modifizierung eines molekularsiebes. | |
DE3677838D1 (de) | Verfahren zur herstellung von alkylestern von 3,4-epoxybuttersaeure. | |
ATE132535T1 (de) | Verfahren zur diskontinuierlichen herstellung von l-carnitin auf mikrobiologischem weg | |
AT361906B (de) | Verfahren zur herstellung von neuen 2,4,6- trijodbenzonitrilen sowie deren estern, saeure- amiden und salzen | |
DE58905010D1 (de) | Verfahren zur herstellung von 5-chlor-3-chlorsulfonyl-2-thiophencarbonsaeureestern. | |
DE3765370D1 (de) | Verfahren zur herstellung eines o-naphtochinondiazidsulfonsaeureesters. | |
ATE207139T1 (de) | Verfahren zur herstellung von butantetracarbonsäure | |
ATE144982T1 (de) | Verfahren zur enantiomerentrennung von 5-hetaryl- 1,3,4-thiadiazinon | |
ATE119899T1 (de) | Verfahren zum herstellen von cyclischen kohlensäureestern. | |
ATE156811T1 (de) | Zwischenprodukte zur herstellung von vitamin a und von carotenoiden und verfahren zu deren herstellung | |
DE59305557D1 (de) | Verfahren zur Herstellung von L-Lysin durch Fermentation von coryneformen Bakterien | |
ATE157967T1 (de) | Zwischenprodukte zur herstellung von vitamin a und von carotenoiden und verfahren zu deren herstellung | |
DE3584528D1 (de) | Katalytisches verfahren zur herstellung von amiden. | |
ATA293888A (de) | Verfahren zur herstellung eines randflansches sowie nach diesem verfahren hergestellter randflansch |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8328 | Change in the person/name/address of the agent |
Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN |
|
8339 | Ceased/non-payment of the annual fee |